BioLargo's water technologies closer to commercialization, reports record 3Q

Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/934217/biolargo-s-water-technologies-closer-to-commercialization-reports-record-3q-934217.html)  

BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which he says will lead to first sales.

What's more, its industrial operating divisions each have a backlog of revenue-generating projects that collectively exceed $2 million, which it says will provide “reliable revenue” into 2021.

Clyraguard Highlighted in Rolling Stone and Men's Journal

BioLargo and its subsidiary Clyra Medical Technologies are rolling out Clyraguard around the country, and it's starting to turn some heads. Now that the product is available on the company's website and on Amazon, the timing is perfect.

Last week, two articles were published about Clyraguard that do a great job capturing the value of this product. First, a Rolling Stone article highlighted how Clyraguard can help improve mask-wearing practices to help keep people safe. Second, a Men's Journal article reviewed the product from a broader perspective.

You can get to these articles right here:

• Rolling Stone article
• Men's Journal article

If you are a follower of BioLargo or Clyra, we'd love to hear your thoughts about the new product. Make sure to follow us on social media - you can find us at:

• Twitter: @BioLargo
• Facebook: https://www.facebook.com/BioLargo1 
• LinkedIn: https://www.linkedin.com/company/biolargo-inc.